{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:04:59Z","timestamp":1791309899724,"version":"4.3.1"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005635","name":"Funda\u00e7\u00e3o Calouste Gulbenkian","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"ANRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008656","name":"FINOVI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008656","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002915","name":"FRM","doi-asserted-by":"publisher","award":["DEQ20110421327"],"award-info":[{"award-number":["DEQ20110421327"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hoffmann-La-Roche Ltd"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.antiviral.2015.08.009","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T19:22:17Z","timestamp":1439320937000},"page":"112-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options"],"prefix":"10.1016","volume":"122","author":[{"given":"Dulce","family":"Alfaiate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"D\u00e9ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Durantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Special issue","key":"10.1016\/j.antiviral.2015.08.009_b0005","first-page":"1038A","article-title":"Model of HBV\/HDV super-infection to study mechanisms of viral interplay and antivirals","volume":"60","author":"Alfaiate","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3851\/IMP2595","article-title":"Epidemiological update of hepatitis B, C and delta in Latin America","volume":"18","author":"Alvarado-Mora","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2015.08.009_b0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.virol.2010.08.019","article-title":"Intrinsic disorder and oligomerization of the hepatitis delta virus antigen","volume":"407","author":"Alves","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0020","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/JCM.02297-13","article-title":"Characterization of hepatitis delta virus in sub-Saharan Africa","volume":"52","author":"Andernach","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","article-title":"Cytotoxic CD4 T cells in viral hepatitis","volume":"13","author":"Aslan","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2015.08.009_b0030","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1128\/JVI.78.10.5233-5243.2004","article-title":"Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes","volume":"78","author":"Barrera","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2013.12.017","article-title":"Conserved features of an RNA promoter for RNA polymerase II determined from sequence heterogeneity of a hepatitis delta virus population","volume":"450\u2013451","author":"Beeharry","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1987.03400040077025","article-title":"Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin","volume":"258","author":"Bensabath","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2015.08.009_b0045","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/JVI.70.5.3248-3251.1996","article-title":"A novel form of hepatitis delta antigen","volume":"70","author":"Bichko","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0050","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1128\/JVI.70.9.5807-5811.1996","article-title":"Epitopes exposed on hepatitis delta virus ribonucleoproteins","volume":"70","author":"Bichko","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0055","doi-asserted-by":"crossref","first-page":"e1004032","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.08.009_b0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2015.08.009_b0065","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/JVI.00096-07","article-title":"Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues","volume":"81","author":"Blanchet","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2014.03.017","article-title":"Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle","volume":"106","author":"Blanchet","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2015.08.009_b0075","first-page":"1279A","article-title":"A proof-of-concept Phase 2a clinical trial with HBV\/HDV entry inhibitor Myrcludex B","volume":"60","author":"Bogomolov","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI17704","article-title":"In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus","volume":"112","author":"Bordier","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2015.08.009_b0085","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1128\/JVI.76.20.10465-10472.2002","article-title":"A prenylation inhibitor prevents production of infectious hepatitis delta virus particles","volume":"76","author":"Bordier","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0090","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/aid.2013.0008","article-title":"Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients","volume":"29","author":"Boyd","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.antiviral.2015.08.009_b0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/S0037-86822012000600007","article-title":"Hepatitis D virus infection in the Western Brazilian Amazon \u2013 far from a vanishing disease","volume":"45","author":"Braga","year":"2012","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.antiviral.2015.08.009_b0100","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2014.05.041","article-title":"Chronic HDV\/HBV co-infection: predictors of disease stage \u2013 a case series of HDV-3 patients","volume":"61","author":"Braga","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.274.5284.90","article-title":"A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution","volume":"274","author":"Brazas","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.009_b0110","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cgh.2013.01.025","article-title":"Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia","volume":"11","author":"Brichler","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/sti.74.6.395","article-title":"Sexual transmission and prevention of the hepatitis viruses A\u2013E and G","volume":"74","author":"Brook","year":"1998","journal-title":"Sex Transm. Infect."},{"key":"10.1016\/j.antiviral.2015.08.009_b0120","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2893.2010.01324.x","article-title":"Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study","volume":"18","author":"Buti","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2015.08.009_b0125","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1111\/jvh.12251","article-title":"Development and evaluation of a baseline-event-anticipation score for hepatitis delta","volume":"21","author":"Calle Serrano","year":"2014","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2015.08.009_b0130","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1261\/rna.1782209","article-title":"Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication","volume":"15","author":"Cao","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.antiviral.2015.08.009_b0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/infdis\/151.5.925","article-title":"Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome","volume":"151","author":"Caredda","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0140","first-page":"123","article-title":"Control of ADAR1 editing of hepatitis delta virus RNAs","volume":"353","author":"Casey","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0145","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/174.5.920","article-title":"Hepatitis B virus (HBV)\/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F","volume":"174","author":"Casey","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2893.2007.00903.x","article-title":"Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome","volume":"15","author":"Castellares","year":"2008","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2015.08.009_b0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/emboj\/21.1.157","article-title":"In vivo RNA-directed transcription, with template switching, by a mammalian RNA polymerase","volume":"21","author":"Chang","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2015.08.009_b0160","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1073\/pnas.88.19.8490","article-title":"The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus","volume":"88","author":"Chang","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b0165","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/JVI.75.7.3469-3473.2001","article-title":"Replication of the human hepatitis delta virus genome is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences","volume":"75","author":"Chang","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0170","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1128\/JVI.79.13.8182-8188.2005","article-title":"Development of a novel system to study hepatitis delta virus genome replication","volume":"79","author":"Chang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0175","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/JVI.01758-07","article-title":"Transcription of hepatitis delta virus RNA by RNA polymerase II","volume":"82","author":"Chang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0180","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JCM.01154-10","article-title":"Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan","volume":"49","author":"Chang","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0185","doi-asserted-by":"crossref","first-page":"13310","DOI":"10.1128\/JVI.79.21.13310-13316.2005","article-title":"Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture","volume":"79","author":"Chang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virusres.2007.01.003","article-title":"RNA recombination in hepatitis delta virus: implications regarding the abilities of mammalian RNA polymerases","volume":"127","author":"Chao","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.08.009_b0195","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1128\/JVI.64.10.5066-5069.1990","article-title":"Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication","volume":"64","author":"Chao","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jmv.1890430414","article-title":"Evolution rate of hepatitis delta virus RNA isolated in Taiwan","volume":"43","author":"Chao","year":"1994","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0205","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1073\/pnas.83.22.8774","article-title":"Structure and replication of the genome of the hepatitis delta virus","volume":"83","author":"Chen","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2006.10.038","article-title":"Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis","volume":"132","author":"Choi","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0215","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1128\/JVI.72.5.3684-3690.1998","article-title":"Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA","volume":"72","author":"Chou","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0645","unstructured":"Chudy M., Hanschmann K.-M., Bozdayi M., Kre\u00df J., N\u00fcbling M., WHO Expert Committee on Biological Standardization (2013: Geneva S, et al. Collaborative study to establish a World Health Organization international standard for hepatitis D virus RNA for nucleic acid amplification technique (NAT)-based assays. 2013 [cit\u00e9 28 f\u00e9vr 2015]. Available from: http:\/\/apps.who.int\/\/iris\/handle\/10665\/96341."},{"key":"10.1016\/j.antiviral.2015.08.009_b0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrgastro.2013.164","article-title":"Chronic hepatitis D at a standstill: where do we go from here?","volume":"11","author":"Ciancio","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2334-14-94","article-title":"Molecular epidemiology of hepatitis B and hepatitis delta viruses circulating in the Western Amazon region, North Brazil","volume":"14","author":"Crispim","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jmv.21078","article-title":"The increasing prevalence of hepatitis delta virus (HDV) infection in South London","volume":"80","author":"Cross","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2014.03.002","article-title":"Mouse models of hepatitis B and delta virus infection","volume":"410","author":"Dandri","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2015.08.009_b0240","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0245","first-page":"151","article-title":"Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?","volume":"307","author":"D\u00e9ny","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0250","doi-asserted-by":"crossref","first-page":"16151","DOI":"10.1073\/pnas.1308049110","article-title":"Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes","volume":"110","author":"Drexler","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0260","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","article-title":"Clinical features of hepatitis D","volume":"32","author":"Farci","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0265","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/infdis\/155.5.931","article-title":"Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B","volume":"155","author":"Fattovich","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0270","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.46.3.420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)","volume":"46","author":"Fattovich","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2015.08.009_b0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jviromet.2011.11.001","article-title":"Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard","volume":"179","author":"Ferns","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2015.08.009_b0280","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1016\/S0264-410X(01)00245-6","article-title":"Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine","volume":"19","author":"Fiedler","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.08.009_b0285","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1128\/JVI.00645-13","article-title":"Prime\/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus","volume":"87","author":"Fiedler","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0290","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/JCM.38.9.3311-3316.2000","article-title":"Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains","volume":"38","author":"Flodgren","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0032-1323624","article-title":"Viroids and hepatitis delta virus","volume":"32","author":"Flores","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0300","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1128\/JVI.00346-14","article-title":"Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus","volume":"88","author":"Freitas","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0310","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12072-010-9178-2","article-title":"Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units","volume":"4","author":"Galizzi","year":"2010","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.antiviral.2015.08.009_b0315","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2013.11.010","article-title":"Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection","volume":"60","author":"Giersch","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2015.03.011","article-title":"Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection","author":"Giersch","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0325","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jgh.12217","article-title":"Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California","volume":"28","author":"Gish","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0330","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.1598578","article-title":"Identification of a prenylation site in delta virus large antigen","volume":"256","author":"Glenn","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.009_b0335","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/368389","article-title":"Synergistic activation of the serum response element-dependent pathway by hepatitis B virus x protein and large-isoform hepatitis delta antigen","volume":"187","author":"Goto","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0340","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.27595","article-title":"Effect of interferon-alfa therapy on hepatitis D virus","volume":"61","author":"Goyal","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0345","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1478-3231.2011.02593.x","article-title":"Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment","volume":"31","author":"Grabowski","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2015.08.009_b0350","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/v2010189","article-title":"Interaction of host cellular proteins with components of the hepatitis delta virus","volume":"2","author":"Greco-Stewart","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2015.08.009_b0355","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virol.2006.08.010","article-title":"The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome","volume":"357","author":"Greco-Stewart","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0360","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2009.02.007","article-title":"The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III","volume":"386","author":"Greco-Stewart","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0365","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1128\/JVI.00443-14","article-title":"Hepatitis delta antigen requires a flexible quasi-double-stranded RNA structure to bind and condense hepatitis delta virus RNA in a ribonucleoprotein complex","volume":"88","author":"Griffin","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0370","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/viro.1995.0002","article-title":"Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity","volume":"213","author":"Gripon","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0375","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0380","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(87)92293-8","article-title":"Long-term delta antigenaemia without appearance of delta antibody in two immunodeficient patients","volume":"1","author":"Grippon","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.009_b0385","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1128\/JVI.74.16.7204-7210.2000","article-title":"Origin of hepatitis delta virus mRNA","volume":"74","author":"Gudima","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0390","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1128\/JVI.76.8.3709-3719.2002","article-title":"Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA","volume":"76","author":"Gudima","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0395","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1261\/rna.7164905","article-title":"Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs","volume":"11","author":"Gudima","year":"2005","journal-title":"RNA"},{"key":"10.1016\/j.antiviral.2015.08.009_b0400","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1128\/JVI.02277-06","article-title":"Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes","volume":"81","author":"Gudima","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0405","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/JVI.68.2.1052-1058.1994","article-title":"Expression of the hepatitis delta virus large and small antigens in transgenic mice","volume":"68","author":"Guilhot","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0410","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajpath.2013.09.008","article-title":"Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice","volume":"184","author":"Gutti","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0415","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.1840050404","article-title":"Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers","volume":"5","author":"Hadziyannis","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0420","doi-asserted-by":"crossref","first-page":"e22415","DOI":"10.1371\/journal.pone.0022415","article-title":"Interferon impedes an early step of hepatitis delta virus infection","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.08.009_b0425","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcv.2014.05.021","article-title":"Molecular epidemiology of hepatitis delta virus in the Western Pacific region","volume":"61","author":"Han","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0430","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2893.2005.00663.x","article-title":"The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells","volume":"13","author":"Hartwig","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2015.08.009_b0435","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jhep.2004.06.025","article-title":"Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection","volume":"41","author":"Hartwig","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0440","doi-asserted-by":"crossref","first-page":"e1004840","DOI":"10.1371\/journal.ppat.1004840","article-title":"Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide","volume":"11","author":"He","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.08.009_b0445","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0450","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1261\/rna.034744.112","article-title":"Activation of PKR by RNA misfolding: HDV ribozyme dimers activate PKR","volume":"18","author":"Heinicke","year":"2012","journal-title":"RNA"},{"key":"10.1016\/j.antiviral.2015.08.009_b0455","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/JCM.00940-14","article-title":"Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification","volume":"52","author":"Homs","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0460","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1128\/JVI.64.7.3192-3198.1990","article-title":"Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen","volume":"64","author":"Hsieh","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0465","doi-asserted-by":"crossref","first-page":"25166","DOI":"10.1074\/jbc.M010087200","article-title":"The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.08.009_b0470","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1099\/vir.0.81718-0","article-title":"Induction of hepatitis D virus large antigen translocation to the cytoplasm by hepatitis B virus surface antigens correlates with endoplasmic reticulum stress and NF-kappaB activation","volume":"87","author":"Huang","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0475","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1128\/JVI.02809-06","article-title":"Large hepatitis delta antigen is a novel clathrin adaptor-like protein","volume":"81","author":"Huang","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0480","doi-asserted-by":"crossref","first-page":"12314","DOI":"10.1128\/JVI.01044-09","article-title":"Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus","volume":"83","author":"Huang","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0485","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1128\/JVI.00873-12","article-title":"Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis","volume":"86","author":"Huang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0490","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1099\/vir.0.80183-0","article-title":"Identification of novel HLA-A\u22170201-restricted CD8+ T-cell epitopes on hepatitis delta virus","volume":"85","author":"Huang","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0495","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.009_b0500","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1128\/JVI.67.12.7659-7662.1993","article-title":"Isoprenylation mediates direct protein\u2013protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen","volume":"67","author":"Hwang","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0505","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00239-001-0064-3","article-title":"Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis","volume":"54","author":"Jenkins","year":"2002","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0510","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnci\/djs168","article-title":"A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma","volume":"104","author":"Ji","year":"2012","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.antiviral.2015.08.009_b0515","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1128\/JVI.01161-14","article-title":"Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies","volume":"88","author":"Julithe","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(15)00074-2","article-title":"Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial","author":"Koh","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0525","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2013.10.040","article-title":"A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections","volume":"441","author":"Kosaka","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2015.08.009_b0530","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/infdis\/jis273","article-title":"A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses","volume":"205","author":"Krepstakies","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0535","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/JVI.62.6.1855-1861.1988","article-title":"Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications","volume":"62","author":"Kuo","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0540","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1128\/JVI.62.12.4439-4444.1988","article-title":"Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus","volume":"62","author":"Kuo","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0545","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1128\/JVI.63.5.1945-1950.1989","article-title":"Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen","volume":"63","author":"Kuo","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0550","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1128\/JVI.79.13.7951-7958.2005","article-title":"RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus","volume":"79","author":"Lai","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058340","article-title":"Proteoglycans act as cellular hepatitis delta virus attachment receptors","volume":"8","author":"Lamas Longarela","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.08.009_b0560","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0565","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.1128\/JVI.01594-09","article-title":"The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent","volume":"83","author":"Le Duff","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0570","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1128\/JCM.43.5.2363-2369.2005","article-title":"Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients","volume":"43","author":"Le Gal","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0575","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid1209.060112","article-title":"Eighth major clade for hepatitis delta virus","volume":"12","author":"Le Gal","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0305","first-page":"1332","volume":"45","author":"Le Gal","year":"2007"},{"key":"10.1016\/j.antiviral.2015.08.009_b0580","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0042-6822(92)90756-F","article-title":"Evolution of hepatitis delta virus RNA during chronic infection","volume":"188","author":"Lee","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0585","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1074\/jbc.M004477200","article-title":"A novel chromosome region maintenance 1-independent nuclear export signal of the large form of hepatitis delta antigen that is required for the viral assembly","volume":"276","author":"Lee","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.08.009_b0590","first-page":"122","article-title":"Role of glycosaminoglycans for binding and infection of hepatitis B virus","volume":"10","author":"Leistner","year":"2008","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0595","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1128\/JVI.02650-05","article-title":"RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0600","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1099\/vir.0.007211-0","article-title":"Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells","volume":"90","author":"Liao","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0605","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1128\/JVI.01723-09","article-title":"Multimerization of hepatitis delta antigen is a critical determinant of RNA binding specificity","volume":"84","author":"Lin","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0610","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1128\/JVI.75.16.7489-7493.2001","article-title":"Efficient hepatitis delta virus RNA replication in avian cells requires a permissive factor(s) from mammalian cells","volume":"75","author":"Liu","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0615","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.1998.9364","article-title":"Characterization of mRNA for hepatitis delta antigen: exclusion of the full-length antigenomic RNA as an mRNA","volume":"250","author":"Lo","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0620","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0625","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.276.5313.824","article-title":"Delta-interacting protein A and the origin of hepatitis delta antigen","volume":"276","author":"Long","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.009_b0630","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jinf.2013.06.008","article-title":"Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study","volume":"67","author":"Lunel-Fabiani","year":"2013","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2015.08.009_b0635","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0640","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"L\u00fctgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0650","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/JVI.76.8.3928-3935.2002","article-title":"Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing","volume":"76","author":"Macnaughton","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0655","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/JVI.00393-13","article-title":"Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment","volume":"87","author":"Macovei","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0660","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/JCM.02012-08","article-title":"Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa","volume":"47","author":"Makuwa","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0665","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1099\/0022-1317-75-6-1371","article-title":"Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA","volume":"75","author":"McNair","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0670","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/JCM.00084-10","article-title":"Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics","volume":"48","author":"Mederacke","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0675","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jprot.2013.06.002","article-title":"Proteomic changes in HEK-293 cells induced by hepatitis delta virus replication","volume":"89","author":"Mendes","year":"2013","journal-title":"J. Proteomics"},{"key":"10.1016\/j.antiviral.2015.08.009_b0680","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0685","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1128\/JVI.74.16.7375-7380.2000","article-title":"The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication","volume":"74","author":"Modahl","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0690","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1128\/MCB.20.16.6030-6039.2000","article-title":"RNA-dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases","volume":"20","author":"Modahl","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0695","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmj.286.6359.87","article-title":"Clinical aspects of delta infection","volume":"286","author":"Moestrup","year":"1983","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"10.1016\/j.antiviral.2015.08.009_b0700","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jprot.2007.12.002","article-title":"Changes in the proteome of Huh7 cells induced by transient expression of hepatitis D virus RNA and antigens","volume":"71","author":"Mota","year":"2008","journal-title":"J. Proteomics"},{"key":"10.1016\/j.antiviral.2015.08.009_b0705","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jprot.2008.12.003","article-title":"Proteome analysis of a human liver carcinoma cell line stably expressing hepatitis delta virus ribonucleoproteins","volume":"72","author":"Mota","year":"2009","journal-title":"J. Proteomics"},{"key":"10.1016\/j.antiviral.2015.08.009_b0710","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/JVI.63.4.1612-1618.1989","article-title":"Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks","volume":"63","author":"Negro","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0715","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1128\/JVI.67.6.3357-3362.1993","article-title":"Experimental transmission of human hepatitis delta virus to the laboratory mouse","volume":"67","author":"Netter","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0720","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0168-8278(99)80185-8","article-title":"Intrafamilial transmission of hepatitis delta virus: molecular evidence","volume":"30","author":"Niro","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0725","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2893.2005.00601.x","article-title":"Treatment of hepatitis D","volume":"12","author":"Niro","year":"2005","journal-title":"J. Viral Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0730","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2010.06.008","article-title":"Outcome of chronic delta hepatitis in Italy: a long-term cohort study","volume":"53","author":"Niro","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0735","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/JVI.71.3.2241-2251.1997","article-title":"Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles","volume":"71","author":"Nisini","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0740","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","article-title":"Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor","volume":"60","author":"Nkongolo","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0745","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1128\/AAC.01003-13","article-title":"Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro","volume":"57","author":"Noordeen","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.08.009_b0750","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/AAC.01005-13","article-title":"Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo","volume":"57","author":"Noordeen","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.08.009_b0755","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11894-013-0365-x","article-title":"Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery","volume":"16","author":"Noureddin","year":"2014","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.antiviral.2015.08.009_b0760","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-0032-1323627","article-title":"Hepatitis delta virus diagnosis","volume":"32","author":"Olivero","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0765","first-page":"1648","article-title":"Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months","volume":"58","author":"Ormeci","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0770","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/0016-5085(91)90404-9","article-title":"Patterns of hepatitis delta virus reinfection and disease in liver transplantation","volume":"101","author":"Ottobrelli","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0775","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jmv.20755","article-title":"High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses","volume":"78","author":"Oyunsuren","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0780","first-page":"48","article-title":"Hepatitis virus (HBV, HCV, HDV) markers in chronic liver diseases. Comparative studies in two East-Central European countries","volume":"133","author":"P\u00e1r","year":"1992","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.antiviral.2015.08.009_b0785","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10059-009-0100-5","article-title":"Hepatitis delta virus large antigen sensitizes to TNF-alpha-induced NF-kappaB signaling","volume":"28","author":"Park","year":"2009","journal-title":"Mol. Cells"},{"key":"10.1016\/j.antiviral.2015.08.009_b0790","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/JVI.01609-10","article-title":"Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses","volume":"85","author":"Pollicino","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0795","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1128\/JVI.69.8.4880-4887.1995","article-title":"Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle","volume":"69","author":"Polo","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0800","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/380454a0","article-title":"RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase","volume":"380","author":"Polson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.08.009_b0805","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1073\/pnas.81.7.2208","article-title":"Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck","volume":"81","author":"Ponzetto","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b0810","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00237100","article-title":"Epidemiology of hepatitis delta virus (HDV) infection","volume":"1","author":"Ponzetto","year":"1985","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0815","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.22654","article-title":"Hepatitis delta virus inhibits alpha interferon signaling","volume":"49","author":"Pugnale","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0820","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/JVI.78.5.2537-2544.2004","article-title":"Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades","volume":"78","author":"Radjef","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0825","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1073\/pnas.97.1.424","article-title":"A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs","volume":"97","author":"Reid","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b0830","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s15010-012-0287-9","article-title":"Hepatitis delta: on soft paws across Germany","volume":"40","author":"Reinheimer","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2015.08.009_b0835","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-381286-5.00004-4","article-title":"HDV family of self-cleaving ribozymes","volume":"120","author":"Riccitelli","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.antiviral.2015.08.009_b0840","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0032-1323626","article-title":"Epidemiology of hepatitis D","volume":"32","author":"Rizzetto","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0845","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gut.18.12.997","article-title":"Immunofluorescence detection of new antigen-antibody system (delta\/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers","volume":"18","author":"Rizzetto","year":"1977","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2015.08.009_b0850","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(79)92561-3","article-title":"Incidence and significance of antibodies to delta antigen in hepatitis B virus infection","volume":"2","author":"Rizzetto","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.009_b0855","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(80)91678-5","article-title":"Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers","volume":"1","author":"Rizzetto","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.08.009_b0860","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/141.5.590","article-title":"Transmission of the hepatitis B virus-associated delta antigen to chimpanzees","volume":"141","author":"Rizzetto","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0865","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1073\/pnas.77.10.6124","article-title":"Delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees","volume":"77","author":"Rizzetto","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b0870","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.274.5284.66","article-title":"How did replicating and coding RNAs first get together?","volume":"274","author":"Robertson","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.009_b0875","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0032-1323631","article-title":"Perspectives for a vaccine against hepatitis delta virus","volume":"32","author":"Roggendorf","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b0880","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0885","doi-asserted-by":"crossref","first-page":"e92062","DOI":"10.1371\/journal.pone.0092062","article-title":"High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta","volume":"9","author":"Romeo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.08.009_b0890","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/JVI.66.4.2310-2315.1992","article-title":"Assembly of hepatitis delta virus particles","volume":"66","author":"Ryu","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0895","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1128\/JVI.67.6.3281-3287.1993","article-title":"Ribonucleoprotein complexes of hepatitis delta virus","volume":"67","author":"Ryu","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0900","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.3748\/wjg.v20.i24.7635","article-title":"Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy","volume":"20","author":"Sagnelli","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0905","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1126\/science.1129308","article-title":"A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene","volume":"313","author":"Salehi-Ashtiani","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.009_b0910","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jmv.10427","article-title":"Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt","volume":"70","author":"Saudy","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0915","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2009.10.036","article-title":"Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D","volume":"52","author":"Schaper","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0920","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JCM.06829-11","article-title":"Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA","volume":"50","author":"Scholtes","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0925","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0930","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction","volume":"84","author":"Schulze","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0935","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2172","article-title":"Ribozymes, riboswitches and beyond: regulation of gene expression without proteins","volume":"8","author":"Serganov","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2015.08.009_b0940","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2013.11.016","article-title":"Increasing prevalence of HDV\/HBV infection over 15 years in France","volume":"59","author":"Servant-Delmas","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0945","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JVI.63.3.1428-1430.1989","article-title":"Self-ligating RNA sequences on the antigenome of human hepatitis delta virus","volume":"63","author":"Sharmeen","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0950","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.510270636","article-title":"Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope","volume":"27","author":"Smedile","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0955","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1097\/QAD.0000000000000417","article-title":"Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients","volume":"28","author":"Soriano","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2015.08.009_b0960","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jmv.21643","article-title":"Italian Hospitals\u2019 Collaborating Group. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study","volume":"81","author":"Stroffolini","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0965","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2006.01.035","article-title":"Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients","volume":"130","author":"Su","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0970","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-60761-688-7_25","article-title":"The use of hepatocytes to investigate HDV infection: the HDV\/HepaRG model","volume":"640","author":"Sureau","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0975","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.26125","article-title":"A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant","volume":"57","author":"Sureau","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b0980","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1128\/JVI.65.7.3443-3450.1991","article-title":"Tissue culture system for infection with human hepatitis delta virus","volume":"65","author":"Sureau","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0985","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JVI.67.1.366-372.1993","article-title":"Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion","volume":"67","author":"Sureau","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0990","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1128\/JVI.68.6.4063-4066.1994","article-title":"The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus","volume":"68","author":"Sureau","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b0995","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jvh.12228","article-title":"Identification of a natural intergenotypic recombinant hepatitis delta virus genotype 1 and 2 in Vietnamese HBsAg-positive patients","volume":"22","author":"Sy","year":"2015","journal-title":"J. Viral Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1000","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S1355838202026432","article-title":"Hepatitis delta virus ribonucleoproteins shuttle between the nucleus and the cytoplasm","volume":"8","author":"Tavanez","year":"2002","journal-title":"RNA"},{"key":"10.1016\/j.antiviral.2015.08.009_b1005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(09)74003-5","article-title":"Chapter 3. Replication of the hepatitis delta virus RNA genome","volume":"74","author":"Taylor","year":"2009","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2015.08.009_b1010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0032-1323623","article-title":"Virology of hepatitis D virus","volume":"32","author":"Taylor","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b1015","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3748\/wjg.v20.i11.2971","article-title":"Host RNA circles and the origin of hepatitis delta virus","volume":"20","author":"Taylor","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1020","doi-asserted-by":"crossref","first-page":"e15784","DOI":"10.1371\/journal.pone.0015784","article-title":"Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus","volume":"5","author":"Taylor","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.08.009_b1025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/fmb.10.15","article-title":"Origin of hepatitis delta virus","volume":"5","author":"Taylor","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","article-title":"Strategies to inhibit entry of HBV and HDV into hepatocytes","volume":"147","author":"Urban","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b9000","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(15)30021-0","article-title":"A targeted functional RNAi screen uncovers Glypican 5 as an entry factor for hepatitis B and D viruses","author":"Verrier","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b1035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.dld.2013.11.006","article-title":"No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance","volume":"46","author":"Visco-Comandini","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b1040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1045","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1128\/JVI.79.4.2221-2229.2005","article-title":"RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/323508a0","article-title":"Structure, sequence and expression of the hepatitis delta (delta) viral genome","volume":"323","author":"Wang","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.08.009_b1055","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","volume":"140","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.08.009_b1060","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1073\/pnas.0704000104","article-title":"Involvement of host cellular multivesicular body functions in hepatitis B virus budding","volume":"104","author":"Watanabe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b1065","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b1070","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1126\/science.1178084","article-title":"Widespread occurrence of self-cleaving ribozymes","volume":"326","author":"Webb","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.009_b1075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrgastro.2009.205","article-title":"Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead","volume":"7","author":"Wedemeyer","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1080","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.21590","article-title":"Hepatitis D virus infection \u2013 not a vanishing disease in Europe!","volume":"45","author":"Wedemeyer","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.08.009_b1085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.08.009_b1090","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0168-8278(14)60006-4","article-title":"Prolonged therapy of hepatitis delta for 96 weeks with pegylated-IFN-\u03b1-2a plus tenofovir or placebo does not prevent HDV-DNA relapse after tretament: the HIDIT-2 study","volume":"60","author":"Wedemeyer","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2013.02.006","article-title":"A re-assessment of the epidemiology and patient characteristics of hepatitis D virus infection in inner city London","volume":"66","author":"William Tong","year":"2013","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2015.08.009_b1100","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1099\/vir.0.011239-0","article-title":"Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha\/beta interferon-inducible MxA gene","volume":"90","author":"Williams","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1105","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2893.2012.01597.x","article-title":"Large hepatitis delta antigen activates STAT-3 and NF-\u03baB via oxidative stress","volume":"19","author":"Williams","year":"2012","journal-title":"J. Viral Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1110","doi-asserted-by":"crossref","first-page":"15118","DOI":"10.1073\/pnas.232416799","article-title":"Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1","volume":"99","author":"Wong","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b1115","doi-asserted-by":"crossref","first-page":"e101002","DOI":"10.1371\/journal.pone.0101002","article-title":"Anti-HDV IgM as a marker of disease activity in hepatitis delta","volume":"9","author":"Wranke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.08.009_b1120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1073\/pnas.86.6.1831","article-title":"Human hepatitis delta virus RNA subfragments contain an autocleavage activity","volume":"86","author":"Wu","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.08.009_b1125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/JVI.65.3.1099-1104.1991","article-title":"Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line","volume":"65","author":"Wu","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1130","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/oxfordjournals.molbev.a026075","article-title":"Recombination of hepatitis D virus RNA sequences and its implications","volume":"16","author":"Wu","year":"1999","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.1057925","article-title":"Stimulation of RNA polymerase II elongation by hepatitis delta antigen","volume":"293","author":"Yamaguchi","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.08.009_b1140","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/382133","article-title":"Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction\u2013and its possible correlation with the clinical stage of liver disease","volume":"189","author":"Yamashiro","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b1145","first-page":"3","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2015.08.009_b1150","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/JVI.03540-12","article-title":"Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide","volume":"87","author":"Yan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1155","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/JVI.03478-13","article-title":"Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide","volume":"88","author":"Yan","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1160","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.cgh.2014.01.043","article-title":"Effects of polymorphisms in interferon \u03bb 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection","volume":"12","author":"Yilmaz","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2015.08.009_b1165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0032-1323629","article-title":"Treatment of chronic delta hepatitis","volume":"32","author":"Yurdaydin","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.08.009_b1170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2893.2010.01353.x","article-title":"Natural history and treatment of chronic delta hepatitis","volume":"17","author":"Yurdayd\u0131n","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2015.08.009_b1175","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2014-308943","article-title":"Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure","author":"Zeisel","year":"2015","journal-title":"Gut"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T13:42:26Z","timestamp":1718026946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":236,"alternative-id":["S0166354215001953"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.08.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}